Expanding the opportunities for blocking the renin-angiotensin system: Introduction to a special supplement

Reviews in Cardiovascular Medicine

Volumn 8, Issue SUPPL. 2, 2007, Pages

  Weber, Michael A ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Aliskiren; Heart failure; Hypertension; Renin angiotensin system

Indexed keywords

ALISKIREN; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DNA; HORMONE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PRORENIN; PRORENIN RECEPTOR; RENIN; RENIN INHIBITOR; RENIN RECEPTOR; UNCLASSIFIED DRUG;

CARDIOVASCULAR DISEASE; DRUG INDICATION; HEART FAILURE; HUMAN; HYPERTENSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

AMIDES; FUMARATES; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; RENIN; RENIN-ANGIOTENSIN SYSTEM; TREATMENT OUTCOME;

EID: 33947231839     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Giles TD. Renin-angiotensin system modulation for treatment and prevention of cardiovascular diseases: toward an optimal therapeutic strategy. Rev Cardiovasc Med. 2007;8(suppl 2): S14-S21.
2. Hollenberg NK. The renin system: is direct renin inhibition different from blockade at the AT1 receptor or the angiotensin-converting enzyme step? Rev Cardiovasc Med. 2007;8(suppl 2): S7-S13.
3. Brunner HR, Laragh JH, Baer L, et al. Essential hypertension: renin and aldosterone, heart attack and stroke. New Engl J Med. 1972;286: 441-449.
4. Buhler FR, Laragh JH, Bear L, et al. Piopranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. N Engl J Med. 1972;287:1209-1214.
5. Alderman MH, Madhavan S, Ooi WL, et al. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med. 1991;324:1098-1104.
6. Dzau V, Braunwald E. Resolved and unresolved issues in the prevention and treatment of coronary artery disease: a workshop consensus statement. Am Heart J. 1991;121:1244-1263.
7. Weber MA. The metabolic syndrome. In: Antman E, ed. Cardiovascular Therapeutics. Philadelphia: Elsevier; 2007.
8. Weber MA, Giles TD. Inhibiting the renin-angiotensin system to prevent cardiovascular diseases: do we need a more comprehensive strategy? Rev Cardiov Med. 2006;7:45-54.
9. Neal B, MacMahon S, Chapman N; Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of ACE inhibitors, calcium antagonists and other blood pressure lowering drugs: results of prospectively designed overviews of randomized trials. Lancet. 2000;355:1955-1964.
10. Nguyen G, Burckle C, Sraer JD. The renin receptor: the facts, the promise and the hope. Curr Opin Nephrol Hypertens. 2003;12:51-55.
11. Laragh JH. Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. Am J Med. 1973;55:261-274.
12. Weber MA, Stokes GS, Gain JM. Comparison of the effects on renin release of beta-adrenergic antagonists with differing properties. J Clin Invest. 1974;54:1413-1419.,
13. Drayet JI, Weber MA, Longworth DL, et al. The possible importance of aldosterone as well as renin in the long-term antihypertensive action of propranolol. Am J Med. 1978;64:187-192.
14. Weber MA, Drayer JI, Rev A, et al. Disparate patterns of aldosterone response during diuretic treatment of hypertension. Ann Intern Med. 1977;87:558-563.
15. Weber MA, Lopez-Ovejero JA, Drayer JI, et al. Renin reactivity as a determinant of responsiveness to antihypertensive treatment. Arch Intern Med. 1977;137:284-289.
16. Case DB, Wallace JIM, Keim HJ, et al. Possible role of renin in hypertension as suggested by renin-sodium profiling and converting enzyme inhibition. N Engl J Med. 1977;296:641-646.
17. White WB, Giles TD, Bakris GL, et al. Measuring the efficacy of antihypertensive therapy by ambulatory blood pressure monitoring in the primary care setting. Am Heart J. 2006;151:176-184.
18. Gradman AH, Traub D. The efficacy of aliskiren, a direct renin inhibitor, in the treatment of hypertension. Rev Cardiovasc Med. 2007;8(suppl 2):S22-S30.